Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swati Garg

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
International Journal of Biological Macromolecules|August 26, 2024
Targeting host inducible-heat shock protein 70 with PES-Cl is a promising antiviral strategy against SARS-CoV-2 infection and pathogenesisPrerna Joshi, Swati Garg, Shailendra Mani, et al.
Haematologica|June 18, 2026
Dual CDK2 and CDK4/6 inhibition suppresses Rb/E2F signaling and enhances anti-leukemic activity in acute myeloid leukemiaEllen Weisberg, Basudev Chowdhury, Swati Garg, et al.
Mbio|December 16, 2025
Decoding the multifaceted role of erythrocyte PMCA4b in oxidative stress-mediated malaria protection and artemisinin resistancePriya Agrohi, Swati Garg, Shreeja Biswas, et al.
International Journal of Cancer|September 12, 2017
Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcomaJeremy Lewin, Swati Garg, Beatrice Y Lau, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 20, 2019
<i>TP53</i> mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analysesVictoria Mandilaras, Swati Garg, Michael Cabanero, et al.
Molecular Therapy. Oncology|March 24, 2025
Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy synergy between CARM1 inhibition and IMiDsWei Ni, Swati Garg, Basudev Chowdhury, et al.
Molecular Therapy. Oncology|April 15, 2025
Erratum: Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapyWei Ni, Swati Garg, Basudev Chowdhury, et al.
Hemasphere|April 23, 2025
Phosphatidic acid phosphatase LPIN1 in phospholipid metabolism and stemness in hematopoiesis and AMLKarin Huber, Swati Garg, Lena Schlautmann, et al.
Iscience|May 30, 2024
Targeting <i>Pf</i>Prohibitin 2-Hu-Hsp70A1A complex as a unique approach towards malaria vaccine developmentManisha Marothia, Ankita Behl, Preeti Maurya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2020
EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition ProgressionStephanie Lheureux, Ana Oaknin, Swati Garg, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
International Journal of Biological Macromolecules|August 26, 2024
Targeting host inducible-heat shock protein 70 with PES-Cl is a promising antiviral strategy against SARS-CoV-2 infection and pathogenesisPrerna Joshi, Swati Garg, Shailendra Mani, et al.
Haematologica|June 18, 2026
Dual CDK2 and CDK4/6 inhibition suppresses Rb/E2F signaling and enhances anti-leukemic activity in acute myeloid leukemiaEllen Weisberg, Basudev Chowdhury, Swati Garg, et al.
Mbio|December 16, 2025
Decoding the multifaceted role of erythrocyte PMCA4b in oxidative stress-mediated malaria protection and artemisinin resistancePriya Agrohi, Swati Garg, Shreeja Biswas, et al.
International Journal of Cancer|September 12, 2017
Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcomaJeremy Lewin, Swati Garg, Beatrice Y Lau, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 20, 2019
<i>TP53</i> mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analysesVictoria Mandilaras, Swati Garg, Michael Cabanero, et al.
Molecular Therapy. Oncology|March 24, 2025
Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy synergy between CARM1 inhibition and IMiDsWei Ni, Swati Garg, Basudev Chowdhury, et al.
Molecular Therapy. Oncology|April 15, 2025
Erratum: Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapyWei Ni, Swati Garg, Basudev Chowdhury, et al.
Hemasphere|April 23, 2025
Phosphatidic acid phosphatase LPIN1 in phospholipid metabolism and stemness in hematopoiesis and AMLKarin Huber, Swati Garg, Lena Schlautmann, et al.
Iscience|May 30, 2024
Targeting <i>Pf</i>Prohibitin 2-Hu-Hsp70A1A complex as a unique approach towards malaria vaccine developmentManisha Marothia, Ankita Behl, Preeti Maurya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2020
EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition ProgressionStephanie Lheureux, Ana Oaknin, Swati Garg, et al.
Pageof 10